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In subjects without thyroid disease, thyroid clearance rates have lain between 5 and 40 ml. of plasma cleared of their iodide per minute, averaging 25 ml./min. In 15 subjects with clear thyrotoxicosis, values have always exceeded 100 ml./min. and usually exceed 150. The clearance in myxcedema has been a few ml./min. only, and its value in non-toxic goitre has been normal or a little raised, one value of 60 having been observed. The renal clearance for iodide has averaged 30 ml./min., and is unchanged in thyrotoxicosis.
Since at all times the thyroid and kidneys are taking up iodide in proportion to their clearance rates, the amounts in thyroid and urine at the end of the uptake phase should approximately measure the ratio of these rates. After twenty-four hours, most of the dose is in fact shared between thyroid and urine in about this ratio, the amount in the tissues being under 10% except in cases of thyrotoxicosis with rapid output from the thyroid. The urinary excretion by twenty-four hours is then a rough measure of the ratio between renal clearance and the combined renal and thyroid clearance. It affords therefore an easily determined index which is influenced by the thyroid clearance. Unfortunately, the renal clearance for iodide varies widely in normal subjects and also influences the 24-hour output of the dose, and the effects of a high thyroid clearance may be simulated by a low renal clearance. It is probably for this reason that the values from the urinary excretion test in normal and thyrotoxic subjects may overlap. This overlap could be reduced it the renal clearance were also determined, as may be done by liquid counter methods alone, but the test would then become inconveniently long, and certain other indices of differing accuracy and simplicity might be suggested. These vary in the directness with which they estimate thyroid clearance, and therefore in the crispness with which they separate normal from increased thyroid uptake of iodide. For example, a simple comparison of the counting rate opposite the neck to that opposite the thigh at one hour after the dose appears to separate the groups well and the ratio correlates closely with the thyroid clearance. As an even simpler test, the plasma radio-iodide concentration two hours after an oral or intravenous dose promises to separate the groups cleanly and it would be simple to give the dose to an outpatient, orally and several hours after food, with instructions that she return for a blood sample two hours later. The plasma could then be compared in a liquid counter with a standard containing 2 % of the dose per litre, since the normal values have been above, and those in thyrotoxicosis below, this figure. If a simple clinical test were required a number of patients could be examined in this way within an hour. For any closer analysis of the degree of thyroid overactivity in taking up iodide, the rather more complex but more direct index of thyroid clearance rate appears to be preferable, and seems likely to be of value in the analysis both of thyroid physiology and disease. THE measurement of urinary excretion of radio-active iodine is a simple procedure involving no disturbance of the patient and the minimum of apparatus. Moreover, only small doses of the isotope are required. Dr. Pochin has shown that the proportion of a dose of I131 excreted in the urine varies inversely with thyroid function, but urinary values alone will not give such an exact picture of thyroid function as the iodine clearance rate.
The present investigation was to determine whether the measurement of urinary radioiodine could be used as a routine diagnostic measure in thyroid disease. After preliminary trials a dose of 10 ,uc. of 1131 was found suitable. About 50 gamma of sodium iodide was added as carrier. The radio-activity of urine samples was measured with a glass liquid counter described by Veall, in conjunction with a conventional scaling and quenching unit, and expressed as a percentage of the dose administered.
A comparison of the twenty-four-hour excretion of I 31 in urine was made in 49 patients, in whom clinical evidence indicated normal, increased, or decreased thyroid function.
1 A fuller presentation of this subject has appeared in the Lancet (1949) ii, 456.
In 26 normal subjects, the amount excreted varied from 28 % to 72 % as compared with 5 % to 26% in 19 cases of thyrotoxicosis. In 4 cases of myxcedema the values were within the normal range. A more satisfactory separation was obtained by subdividing the twenty-fourhour period of collection. The excretion of Il3 in the first six hours following the tracer dose is not markedly different in the three groups, but the subsequent period from six to twenty-four hours shows an obvious difference. In this period the excretion in normals varied from 10% to 25 % while the highest amount excreted by the mildest case of thyrotoxicosis was 4 5 %, the average case excreting under 2 %. The difference is not so marked in myxcedema, the values lying between 26% to 33 %. On further analysis it was found that, in general, the summed excretion plotted against time approximated to an exponential form, and'a mean exponential could be drawn through the actual values. This confirmed Keating's. findings, and his method of calculating an index of thyroid iodine collection was then employed.
The thyroid rates in the groups already discussed were as follows. Normal: 0 055 to 0-10. Thyrotoxicosis: 0-28 to 1 18. Myxcedema: 0'005 to 0 04. The more severe the thyrotoxicosis the higher was the thyroid rate, and the rate for the mildest case was over three times the mean normal. Thus the six to twenty-four-hour bulk excretion proved an adequate diagnostic aid, while the thyroid rate gave a more exact picture of the degree of thyroid dysfunction. Investigations were also done in a group of 7 patients in whom clinical observation (including B.M.R.) led to a diagnosis of mild hyperthyroidism insufficient to justify antithyroid therapy. Both the six to twenty-four-hour excretion and thyroid rate in this group fell between the limits of normal and thyrotoxicosis. It seems that such cases represent an intermediate grade of thyroid over-activity, between normal and clinical thyrotoxicosis.
The two most important possibilities of error in assessing thyroid function from urinary excretion of 1131 are failure of renal function, and previous administration of iodine. Four patients with renal failure showed a diminished excretion of the tracer dose (12% to 26% in twenty-four hours) which might give rise to an erroneous impression of thyrotoxicosis. The thyroid rate in these cases was normal, demonstrating that Keating's analysis gives a reasonable correction for changes in renal function. Administration of iodine increases the excretion of 1131. In one case of thyrotoxicosis, treated with iodide for three weeks, excretion values were normal although signs of thyrotoxicosis were still manifest. Clearly, it is important to be sure that no iodine has been given in any form prior to a diagnostic test with 18l and the amount of carrier iodine given with the tracer dose must be kept very low. In this series there was no control of dietary iodine, and it may well be that the variation in excretion of radio-active iodine among normal subjects is partially explained by differences in previous iodine intake. It is noticeable that the average twenty-four-hour excretion for each group in this series is less than that reported for similar groups studied in U.S.A. Again, differences in dietary iodine may explain the discrepancy.
Bearing in mind the limitations of the method, and the fact that it is not a direct measurement of thyroid iodine uptake, the urinary excretion of a dose of 1131 is a simple and useful diagnostic aid in determining thyroid activity. Bulk samples from six to twenty-four hours after the dose give a clear-cut separation between the normal and the thyrotoxic patient, while Keating's more involved calculations produce a closer assessment of the degree of hyperfunction. In myxcedema this calculation is of diagnostic use but requires further study, with collection of urine over a forty-eight-hour period. MUCH has already been published to indicate the potential usefulness of 111' for radiotherapy either of thyroid cancer or of hyperthyroidism. As might be expected, the immature malignant thyroid cell often (60-90%) does not take up iodine. But the great usefulness of radioactive iodine in those cancers which do, can be readily imagined; and some success has even been achieved in stimulating malignant-secondaries which did not originally take up iodine to do so. The use of radio-active iodine, or of other forms of radiation, in the treatment of thyrotoxicosis has, however, little to commend it except in the rare cases for whom other treatments are not practicable or have repeatedly failed. For these cases it probably has much to commeid it. But we have had experience mostly with the possible diagnostic use of radio-active iodine.
